Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07414888

Muscle Strength Asymmetry In Sarkopenic And Non-sarcopenic Older Adults

The purpose of this observational study is to examine whether differences in muscle strength between the dominant and non-dominant sides of the body are associated with sarcopenia in older adults. The study will include adults aged 65 years and older with and without sarcopenia. Muscle strength will be measured on both sides of the body using handgrip strength as well as strength measurements of the biceps (upper arm muscle) and quadriceps (thigh muscle). The difference in strength between the dominant and non-dominant sides will be calculated and compared between participants with sarcopenia and those without sarcopenia.

The main question it aims to answers are:

* Do older adults with sarcopenia have larger differences in muscle strength between the two sides of the body compared with those without sarcopenia? * Can differences in arm and leg muscle strength help identify older adults who may be at higher risk of sarcopenia?

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul Physical Therapy and Rehabilitation Training and Research Hospital

Istanbul, Bahçelievler, 34180, Turkey (Türkiye)

Location contact

nurdan paker, Professor Doctor

CONTACT

[email protected]

+90 532 691 7591

tugba aydın, Associate Professor

SUB_INVESTIGATOR

tugba aydın, associate professor

CONTACT

[email protected]

+90 532c462 2162

ugur c onder, medical resident

PRINCIPAL_INVESTIGATOR

About this study

Sarcopenia is a clinical condition in elderly individuals where muscle strength, muscle mass, and physical performance decrease, negatively impacting their quality of life. The European Working Group on Sarcopenia in Older People (EWGSOP) has developed a simple clinical definition and diagnostic criteria for age-related sarcopenia. Measurements of walking speed, grip strength, and muscle mass are taken to detect sarcopenia. The severity of the disease is It is measured by physical performance. Unilateral measurements in hand grip strength measurement used in diagnosis may lead to the neglect of muscle symmetry. Hand grip strength asymmetry (difference between dominant and non-dominant hands) has recently been evaluated as a sarcopenia risk indicator.A significant association has been demonstrated between handgrip strength asymmetry (>10% difference between limbs) and sarcopenia. Individuals with asymmetry were found to have a 2.67-fold higher risk of sarcopenia, indicating that this approach also has diagnostic utility. In addition, it has been shown that the dominant side has greater strength and muscle mass in the upper extremities; however, this difference decreases with age. A significant relationship has been identified between handgrip strength asymmetry and muscle mass, with asymmetric individuals being more likely to have low muscle mass.. In the lower extremities, quadriceps strength was found to have a clearer relationship with health outcomes. In the ISCOPE study, although the relationship between quadriceps strength and handgrip strength was limited, the combination of the two was found to be appropriate in defining the fragile group. In light of these studies, it can be suggested that dominant-non-dominant muscle strength asymmetry (upper and lower extremities) is greater in sarcopenic individuals and that this asymmetry parameter may have a guiding value in diagnosis. In the current literature, there is no study that evaluates asymmetries between biceps, quadriceps, and handgrip strength together and compares their predictive power specific to sarcopenia. This study aims to compare the differences in dominant-non-dominant biceps, quadriceps, and handgrip strength in sarcopenic and non-sarcopenic elderly individuals, and to examine its potential value as a novel biomarker in the diagnosis of sarcopenia.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 65 years or older
  • Ability to walk independently or with minimal assistance
  • Ability to understand and follow simple instructions
  • Willingness and ability to provide written informed consent
  • Availability of muscle strength measurements (handgrip, biceps, and quadriceps)

Exclusion criteria

  • Lack of cooperation, moderate to severe dementia (e.g., MMSE <24) or conditions impeding cooperation.
  • Those with severe cardiovascular disease
  • Those with pacemakers
  • Surgical/fracture/acute pain in the measured extremities within the last 6 months.
  • Neurological and muscular disease affecting the upper or lower extremity (acute stroke, severe peripheral neuropathy, etc.)
  • Active systemic disease attack significantly affecting the measurement.

Treatment and study plan

Primary outcomes

  1. Biceps Muscle Strength Asymmetry

    Time frame: Baseline

    Difference in biceps muscle strength between the dominant and non-dominant sides measured using Lafayette manual muscle tester.

  2. Quadriceps Muscle Strength Asymmetry

    Time frame: Baseline

    Difference in quadriceps muscle strength between the dominant and non-dominant sides measured using lafayette manual muscle tester.

  3. Handgrip Strength (Dominant and Non-Dominant)

    Time frame: Baseline

    Handgrip strength measured separately for the dominant and non-dominant hands using a hand dynamometer.

Secondary outcomes

  1. Barthel Index of Activities of Daily Living

    Time frame: Baseline

    Functional independence in activities of daily living was assessed using the Barthel Index of Activities of Daily Living. The total score ranges from 0 to 100, with higher scores indicating greater functional independence and lower scores indicating greater dependency.

  2. Functional Ambulation Classification (FAC)

    Time frame: Baseline

    Ambulation ability was evaluated using the Functional Ambulation Classification. The FAC is a 6-point ordinal scale ranging from 0 to 5, where higher scores indicate greater walking independence (0 = non-functional ambulation; 5 = independent ambulation on all surfaces).

  3. Body Composition by Bioelectrical Impedance Analysis (BIA)

    Time frame: Baseline

    Body composition, including muscle mass, assessed using bioelectrical impedance analysis (Tanita device).

  4. Gait Speed (3 m and 4 m Walk Tests)

    Time frame: Baseline

    Gait speed measured over 3-meter and 4-meter walking tests under standardized conditions.

  5. Short Physical Performance Battery (SPPB)

    Time frame: Baseline

    Lower extremity physical performance assessed using the Short Physical Performance Battery.

Study contacts

Contact information is provided by the study sponsor or research team.

Tugba aydın, Associate Professor

CONTACT

[email protected]

+90 532 462 2162

ugur c onder, Medical Resident

CONTACT

[email protected]

+90 553 618 9923

Sponsors and collaborators

Lead sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Other Gov

Registry information

Official study title

Comparison of Dominant and Non-Dominant Side Muscle Strength Asymmetry in Sarcopenic and Non-Sarcopenic Older Adults

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 17, 2026
Registry last updated
Mar 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.